文献速递免疫规划

基于模拟表位的双表位肽疫苗抗播散性念珠菌病设计

Design of a mimotope-peptide based double epitope vaccine against disseminated candidiasis.
PubMed 文献 · Vaccine · 2019-03-28

本研究针对无FDA批准抗真菌疫苗的现状,采用模拟表位肽替代糖表位β-(Man)3,构建双表位肽疫苗。所有5个模拟表位在小鼠中具免疫原性,其中3个可诱导针对播散性念珠菌病的保护,且3种模拟表位-肽偶联疫苗能诱导特异性抗体反应并产生保护。该疫苗设计经济、高效且安全,有望成为人类候选疫苗。

要点

  • 模拟表位肽可替代β-(Man)3糖表位作为免疫原。
  • 5个模拟表位均具免疫原性,3个可诱导小鼠保护。
  • 双表位肽疫苗经济、高效且安全,具候选疫苗潜力。

核心结论

  • 基于模拟表位肽的双表位疫苗是抗播散性念珠菌病的潜在候选疫苗,经济、高效且安全。

研究设计与样本

  • 本研究为临床前小鼠实验,设计模拟表位肽替代糖表位β-(Man)3构建双表位肽疫苗。

主要发现

  • 所有5个选定的模拟表位在小鼠中具免疫原性,其中3个能诱导针对播散性念珠菌病的保护。
  • 3种模拟表位-肽偶联疫苗免疫可诱导特异性抗体反应,并保护小鼠抵抗播散性念珠菌病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hematogenously disseminated candidiasis in humans is the third leading cause of nosocomial bloodstream infections in the US. There is no FDA approved antifungal vaccine or prophylactic/therapeutic antibody for use in humans. We first reported novel synthetic peptide and glycopeptide vaccines against Candida albicans cell surface epitopes that protect mice against disseminated candidiasis. We showed that antibodies specific for the peptide Fba (derived from C. albicans cell surface protein fructose bisphosphate aldolase) or for C. albicans cell surface glycan epitope β-1, 2-mannotriose [β-(Man)3]) are both protective. This is an important step forward in vaccine design against disseminated candidiasis in humans. However, given the complexity of oligosaccharide synthesis, in this study we performed a new strategy for use of peptide mimotopes that structurally mimic the protective glycan epitope β-(Man)3 as surrogate immunogens that substitute for the glycan part of glycopeptide [β-(Man)3-Fba] vaccine. All five selected mimotopes are immunogenic in mice and three mimotopes were able to induce protection in mice against disseminated candidiasis. Furthermore, immunization with three mimotope-peptide conjugate vaccines was also able to induce specific antibody responses, and importantly, protection against disseminated candidiasis in mice. Therefore, our new design of a mimotope-peptide based double epitope vaccine against candidiasis is a potential vaccine candidate that is economical to produce, highly efficacious and safe for use in humans.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Xin H, Glee P, Adams A, et al. Design of a mimotope-peptide based double epitope vaccine against disseminated candidiasis. Vaccine. 2019. PMID: 30930005. doi:10.1016/j.vaccine.2019.03.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。